$30.35 +0.30 (%) Pfizer Inc - NYSE

Sep. 17, 2014 | 04:00 PM

Partner Headlines

  1. MedGenesis Announces Deal with Pfizer Related to Possible Treatments for Parkinson's

    Benzinga | Sep. 16, 2014 | 09:10AM EST
  2. Nasdaq Underperforms As Leading Growth Stocks Take Heat

    IBD | Sep. 15, 2014 | 11:49AM EST
  3. Benzinga's Weekend M&A Chatter

    Benzinga | Sep. 14, 2014 | 18:15PM EST
  4. Why Nine of Fifteen Oil Majors Are Undervalued

    YCharts | Sep. 12, 2014 | 18:34PM EST
  5. Pfizer Inc. Trying To Claw Its Way Back Up After Pullback

    Benzinga | Sep. 10, 2014 | 10:33AM EST
  6. Martoma Hit with Nine-Year Prison Sentence

    FoxBusiness | Sep. 8, 2014 | 16:44PM EST
  7. What Is A High Risk Market?

    Benzinga | Sep. 8, 2014 | 09:39AM EST
  8. Merck PD-1 Inhibitor Approved For Skin Cancer

    IBD | Sep. 4, 2014 | 16:33PM EST
  9. SunTrust Sees Further Pfizer Inc. Bid For AstraZeneca PLC 'Highly Likely'

    Benzinga | Sep. 2, 2014 | 15:35PM EST
  10. Partnering With Big Pharma, Parexel Hits Its Stride

    IBD | Aug. 29, 2014 | 16:14PM EST
  11. Amgen edges up on trial results

    IBD | Aug. 28, 2014 | 18:42PM EST
  12. I Am Sure This Pharma-Company Suits Your Portfolio

    GuruFocus | Aug. 28, 2014 | 13:52PM EST
  13. UPDATE: Protalix Shares Spike Higher on FDA Approval of Pediatric Indication for ELELYSO(TM) for Injection, for IV Use for Treatment of Type 1 Gaucher Disease

    Benzinga | Aug. 28, 2014 | 13:18PM EST
  14. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

    GuruFocus | Aug. 28, 2014 | 12:21PM EST
  15. Fast Money Picks For August 28

    Benzinga | Aug. 27, 2014 | 20:35PM EST
  16. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga | Aug. 27, 2014 | 17:17PM EST
  17. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga | Aug. 27, 2014 | 12:32PM EST
  18. Deutsche Bank Says Pfizer Has A Strong Financial Position And Attractive Pipeline

    Benzinga | Aug. 27, 2014 | 11:25AM EST
  19. Benzinga's Top Initiations

    Benzinga | Aug. 27, 2014 | 09:26AM EST
  20. Deutsche Bank Initiates Pfizer With Buy

    Benzinga | Aug. 27, 2014 | 07:06AM EST
  21. Merck, Pfizer combining drugs

    IBD | Aug. 26, 2014 | 18:45PM EST
  22. HCP Boosts Of 29 Years Of Dividend Increases

    IBD | Aug. 26, 2014 | 17:27PM EST
  23. Economic Data Fuel Another All-Time High For S&P 500

    IBD | Aug. 26, 2014 | 15:36PM EST
  24. Merck, Pfizer Combining Drugs In Lung Cancer Study

    IBD | Aug. 26, 2014 | 12:07PM EST
  25. Pfizer, Merck Report Collaboration on Study Evaluating Novel Anti-Cancer Combo Regimen

    Benzinga | Aug. 26, 2014 | 08:01AM EST
  26. Late-Cycle Nirvana: Moaty Dividends on the Cheap

    YCharts | Aug. 25, 2014 | 23:48PM EST
  27. 3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology

    Benzinga | Aug. 24, 2014 | 20:08PM EST
  28. Nasdaq Leads Mixed Session; Actavis Extends Gains

    IBD | Aug. 22, 2014 | 13:27PM EST
  29. Contract Researcher Parexel Sees Growth In Biotech

    IBD | Aug. 21, 2014 | 15:00PM EST
  30. Illumina Forms Partnerships With Big Pharma Firms

    IBD | Aug. 21, 2014 | 12:03PM EST
  31. Pfizer Could Revive AstraZeneca Bid As Early As Tuesday

    Benzinga | Aug. 21, 2014 | 11:39AM EST
  32. Treasury Develolping Options to Curb Inversions

    FoxBusiness | Aug. 18, 2014 | 13:34PM EST
  33. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus | Aug. 18, 2014 | 11:54AM EST
  34. Pfizer Announces Submission of Palbociclib New Drug Application To The FDA

    Benzinga | Aug. 18, 2014 | 08:01AM EST
  35. Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine

    Benzinga | Aug. 14, 2014 | 17:01PM EST
  36. Buyback ETF Slow-Footed: Better Ideas Here

    YCharts | Aug. 14, 2014 | 15:57PM EST
  37. Buyback Mania Inflates 2Q Earnings Growth

    FoxBusiness | Aug. 14, 2014 | 08:17AM EST
  38. YCharts Research: August 2014 Valuation Snapshot

    YCharts | Aug. 12, 2014 | 23:21PM EST
  39. Pfizer Issues Top-Line Results from Potherpetic Neuralgia, Painful Diabetic Peripheral Neuropathy Studies in China: PDPN Phase 3 Did Not Hit Endpoint, PHN Phase 4 Study Met Primary Endpoint

    Benzinga | Aug. 12, 2014 | 17:04PM EST
  40. Earnings Season Is The Right Prescription For Health Care ETFs

    Benzinga | Aug. 12, 2014 | 16:53PM EST
  41. Intercept Pharma Soars On Positive Liver Drug Data

    IBD | Aug. 11, 2014 | 22:20PM EST
  42. Legendary Investor Irving Kahn's Top Five Stocks

    GuruFocus | Aug. 8, 2014 | 18:57PM EST
  43. Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

    IBD | Aug. 7, 2014 | 12:04PM EST
  44. Walgreen Leads Sell-Off In 'Tax Inversion' Stocks

    IBD | Aug. 6, 2014 | 10:15AM EST
  45. Drugmaker AstraZeneca Returns To Growth

    IBD | Aug. 5, 2014 | 17:22PM EST
  46. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus | Aug. 5, 2014 | 10:51AM EST
  47. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

    Benzinga | Aug. 5, 2014 | 09:16AM EST
  48. Walgreen Names New CFO Ahead of Possible Inversion

    IBD | Aug. 4, 2014 | 12:29PM EST
  49. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus | Aug. 4, 2014 | 11:12AM EST
  50. The Stocks Already in Correction Mode

    FoxBusiness | Aug. 1, 2014 | 08:15AM EST
Trading Center